Conclusions. Blood levels of nitrosylhaemoglobin, a surrogate marker of NO, increased under blockade of Background. The effects of renin-angiotensin system blockade on nitric oxide (NO), especially in patholo-the renin-angiotensin system in patients with IgA nephropathy, but not in healthy volunteers. This gical conditions, are far from being established. The influence of kinins and angiotensin type 2 receptor are increase could contribute to changes of effective renal plasma flow in renal disease states. largely speculative and based mainly on animal studies. This study was aimed to address these aspects in Keywords: angiotensin receptor antagonists; haemohumans.
tion rate (GFR), persistent proteinuria, hypertension, Patients' enrolment and interstitial fibrosis are generally considered indicCase selection among patients biopsied in the 2 months ators of poor prognosis in these patients [8, 9] . preceding the start of the study was based on knowledge of Identification of the haemodynamic mechanism suspatients' therapeutic compliance and acceptance of the taining this evolutive course is presently mandatory in experimental aim of the study. Patients, who gave informed determining therapeutic strategies that interfere with consent for participation in this protocol in accordance with progressive glomerular sclerosis. Among them, block-the guidelines of the local Medical Ethics Committee, were ade of the renin-angiotensin system is currently chosen among those having clinical and histological features thought to be the most rational approach. Indeed, AII generally accepted [22] as poor prognostic indices. induces mesangial contraction [10] , intracellular trap- Table 1 summarizes the main histological data. Patients (seven males and one female, mean age 49.37±14.87 years, ping and mesangial uptake of macromolecules [11, 12] , range 32-73) had persistent proteinuria (>1 g/day) in the glomerular hypertension [13] , and changes in glomerlast 6 months no history of recurrent macroscopic haematuria ular membrane permselectivity [14, 15] . Local hyperacand, with the exception of a female (no. 8 of Table 2 ), a tivity of the renin-angiotensin system in patients with reduced GFR (<75 ml/min). Four patients (nos 2,3,5,7) were high risk of progression has previously been reported hypertensive (blood pressure Á150/95 mm Hg) and four [16 ] .
(nos 3-6) had increased urinary ET1/cGMP ratio (>0.08),
The role of haemodynamic factors in disease pro-known to be associated with ISO5M-dependent decrease in gression is also supported by studies on endothelin 1 FF No definite data are presently available on the Laboratory investigation influence of blockade of the renin-angiotensin system on NO production. Understanding this effect could be Electron paramagnetic resonance ( EPR) was used to detect of particular interest in patients with relentless pro-blood NO using haemoglobin (Hb) as a 'spin trap' to gressive renal insufficiency due to haemodynamic overcome the radical's instability. The identity of the new factors.
compound's spectra was defined by a triplet feature at 3.250-2.400 gauss with g values of 2.02, which was found to be specific for NO-Hb. Extensive details of this method are given elsewhere [19] . A computer system on-line with the EPR spectrometer (Bruker ESP 300) allowed calculation of Subjects and methods spectra. Each spectrum was measured as a derivative of the signal integral of interest normalized for the signal background and expressed as arbitrary units (AU )×10−4 [24] . Eight patients with IgAN were given standard doses over a 7-day period of the AII type 1 receptor antagonist losartan, A radioenzymatic test was used for direct determination of ACE in serum (Buhlmann Labs AG, Switzerland). The the angiotensin converting enzyme inhibitor enalapril, or the NO donor (as a control ) isosorbide 5 mononitrate (ISO5M ). minimum detectable ACE level, determined as the activity at twice the blank value using a 2-h incubation time, was Treatment periods were randomized and separated by a week of study-drug discontinuation in order to clear the pharmaco-found to be 2 units. Plasma renin activity and plasma and urine human aldosterone were detected by specific radiological effects of the previously administered compound before starting the new treatment. Laboratory investigation immunoassay (Biodata, Guidonia Montecello, Italy).
The detection limit of the assays, defined as the concentraincluded detection of GFR, effective plasma renal flow (ERPF ), filtration fraction (FF ), blood NO, plasma renin tion of angiotensin I or aldosterone equivalent to the mean counts of 20 replicates of the zero standard minus 2 SD, was activity, angiotensin converting enzyme (ACE) activity, plasma and urinary aldosterone, and albuminuria. All these 0.039 ng/ml and 6.0 pg/ml respectively. Urinary albumin levels were detected by standard nephelometric method on parameters were assessed before and after each 7-day period.
Seven healthy volunteers from the staff were given enalapril 24-h urine collection. Radioisotopic clearances for estimation of GFR and ERPF were performed as described in detail and losartan according to the same protocol in order to allow evaluation of NO generation under pharmacological elsewhere [25] .
[51Cr] EDTA (Amersham, Buckingamshire, UK ) plasma challenge in normal individuals. 
A-sclerosis, arteriolosclerosis; G-sclerosis, glomerular sclerosis; I-fibrosis, interstitial fibrosis; Capillary Ig, immunoreactants along the peripheral glomerular capillary wall. Presence of crescents and glomerular sclerosis is expressed as percentage of involved glomeruli. Degrees in interstitial fibrosis and tubular atrophy are 1, focal; 2, diffuse; 3, diffuse with interstitial leukocyte infiltration. Biopsies were performed 2-7 weeks before starting the study. (ml/min) was tration of the AT1 receptor antagonist, losartan, ACE the ratio of the injected dose (37 kBq/kg) and the total area inhibitor (ACE-i), enalapril, and NO-donor, ISO5M. . Comparisons in normally distributed variables were patients, no significant influences of both enalapril and addressed by analysis of variance (ANOVA) to compare losartan on nitrosylhaemoglobin levels were observed multiple groups. If statistically significant differences were in controls ( Figure 1b) . Only ACE-i was able to signifound, differences between individual groups were tested by ficantly reduce albuminuria during this 1-week treatStudent's t-test. Linear regression analysis was used to assess ment (P=0.01) in IgAN patients. However, all four correlation between variables.
patients with increased (i.e.>0.08) urinary ET1/cGMP ratio and one out of four with low ratio responded to ISO5M with at least 30% reduction of albuminuria.
Results
Significant relationships were found between NO levels
Discussion
and ERPF (positive correlation, P=0.02) and FF values (negative correlation, P=0.04) detected at the starting point of the study and at the end of the wash-This short-term study focused on the possibility of modifing glomerular haemodynamics by means of curout periods in patients. rently available compounds able to influence with renin-angiotensin system and NO production.
Results obtained from this sample of IgAN patients with definite risk of non-immunological progression toward renal failure showed that the AT1 receptor antagonist losartan and the ACE-i enalapril comparably increased blood NO levels and ERPF and reduced filtration fraction. However, albuminuria was reduced at significant levels only by ACE-i treatment. These data confirmed results of the acute response to captopril previously observed by our group in this subset of IgAN patients [16 ] .
In acute and chronic experimental settings, AT1 receptor antagonist was substantially less potent than the ACE inhibitor in lowering glomerular pressure in the kidney [27, 28] . Specifically, our findings were in agreement with the results of the experimental puromycin aminonucleoside nephrosis [28] , in which an early antiproteinuric effect, (channelled, at least in part, through activation of bradykinin), was found only with ACE-i. However, in other experimental conditions AT1 receptor antagonist and ACE inhibitor were comparable [29] . Gansevoort et al. [3] examined 11 patients with mild renal failure, moderate hypertension, and non-diabetic proteinuria. Renal haemodynamic response was similar to that described in the present paper (including ERPF, GFR, FF, ACE activity, and PRA) except for urinary protein excretion. Apart from differences in underlying nephropathy, baseline proteinuria (greater) and time of administration ( longer in the Gansevoort report), it is worth noticing that, at variance with the earlier study using placebo in washout periods, mean blood pressure values were kept constant throughout the present study, which allowed observation of drugmediated, non-antihypertensive-related effects of the The need of a long-term drug administration for
